Actilyse

Actilyse (Alteplase) is a recombinant tissue plasminogen activator used for intravenous administration. It is commonly associated with clot-busting therapies and is manufactured by Boehringer Ingelheim International Gmbh.

Actilyse is primarily used to dissolve blood clots in the body. It is often administered intravenously to treat conditions where rapid clot dissolution is necessary, such as in the management of acute ischemic stroke or pulmonary embolism. The medication works by converting plasminogen to plasmin, which helps break down fibrin in blood clots.

Common effects of Actilyse may include bleeding at the injection site or other areas of the body. Patients might also experience bruising, nausea, or low blood pressure. These effects are generally monitored by healthcare professionals during administration.

Actilyse should be handled with care to avoid bleeding complications. It is important to inform healthcare providers about any history of bleeding disorders or recent surgeries. The medication should be stored and administered under controlled conditions to ensure its efficacy and safety.

Actilyse may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Alcohol and certain supplements might also influence its effects. Patients should discuss all current medications with their healthcare provider before starting Actilyse therapy.